Archived Monthly Oncology Tumor Boards: Updates in Treatment of Hairy Cell Leukemia
Learn about the recent advances as well as the challenges involved in the diagnosis and management of classical hairy cell leukemia (HCL) and HCL-variant.
Category
  • Non-Hodgkin's Lymphoma
Format
  • Recorded Webcast
Credits
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 CCM clock hours
  • 1.00 Participation
Cost $0.00
Recorded Presentation from the NCCN Pharmacy Updates: Updates in Ovarian Cancer - Putting Together the PARP Puzzle and Understanding a New Therapeutic Target
The flurry of changes to the PARPi indications can cause considerable confusion in clinical practice. It may be difficult for health care professionals to keep track of the emerging data and understand how to apply it to patient care. It is important that health care professionals, including pharmacists, are able to educate their patients on the risks vs. benefits of these agents to help empower them to make informed decisions regarding their treatment.
Category
  • Ovarian Cancer
Format
  • Recorded Webcast
Credits
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 Participation
Cost $0.00
Archived Monthly Oncology Tumor Boards: B-Cell Lymphomas: Histologic Transformation of Indolent Lymphomas
Learn about the challenges associated with the management of transformed indolent lymphomas and the recent advances in management to help you to incorporate novel therapies into routine clinical practice in the appropriate patient population to improve clinical outcomes.
Category
  • Non-Hodgkin's Lymphoma
Format
  • Recorded Webcast
Credits
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 CCM clock hours
  • 1.00 Participation
Cost $0.00
A Model for Responding to Chemotherapy Infusion Hypersensitivity Reactions
Hypersensitivity treatment algorithms and standing orders provide the nurse with the opportunity to feel confident in their ability to manage hypersensitivity and enable them to intervene earlier. Early intervention may lead to better outcomes for the patient and the potential for completion of treatments versus changes to the treatment plan.
Category
  • Supportive Care Topics
Format
  • Recorded Webcast
Credits
  • 0.75 ANCC contact hours
  • 0.75 Participation
Cost $0.00
Management of Colorectal Cancer
Continued education on the advancements of colorectal cancer will help bridge knowledge gaps and improve the quality of care offered to patients.
Category
  • Colorectal Cancer
Format
  • Recorded Webcast
Credits
  • 0.75 ANCC contact hours
  • 0.75 Participation
Cost $0.00
Pain Management in Oncology
Pain management is a crucial component of patient-centered care, particularly in oncology. Since there are many modalities to treat cancer-related pain, education on commonly utilized strategies and pharmacologic agents will be beneficial to improving patient care.
Category
  • Pain
Format
  • Recorded Webcast
Credits
  • 0.75 ANCC contact hours
  • 0.75 Participation
Cost $0.00
Current Treatment Approaches for Transformed Indolent B-Cell Lymphomas
Education about the recent advances and special considerations associated with the diagnosis and management of transformed indolent lymphomas is essential to facilitate the incorporation of novel treatment options into routine clinical practice to improve clinical outcomes.
Category
  • Non-Hodgkin's Lymphoma
Format
  • Recorded Webcast
Credits
  • 0.75 ANCC contact hours
  • 0.75 Participation
Cost $0.00
Updates on Safe Handling
Continued education on this topic and staying informed on the most up-to-date information will always be necessary to improve the overall safety of oncology nursing professionals.
Category
Format
  • Recorded Webcast
Credits
  • 0.75 ANCC contact hours
  • 0.75 Participation
Cost $0.00
NCCN Guidelines® Insights - Systemic Mastocytosis, Version 3.2024
The NCCN Guidelines for Systemic Mastocytosis provide evidence- and consensus-based recommendations for the diagnosis and comprehensive care of patients with systemic mastocytosis. The multidisciplinary panel of experts convenes at least once a year to review requested changes to the guidelines from both internal and external entities as well as to discuss data on existing and new therapies. These NCCN Guidelines Insights focus on some of the recent updates to the guidelines.
Category
  • Myeloproliferative Neoplasms
  • Systemic Mastocytosis
Format
  • Monograph/Journal Supplement
Credits
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 Participation
Cost $0.00
Updates in the Management of Neuroblastoma
Neuroblastoma is a complex pediatric cancer that can be challenging to treat. It is important to be informed of the updated risk classification system for stratifying those with neuroblastoma, as well as the recommended treatment strategies for each risk group, to ensure optimal outcomes for patients.
Category
Format
  • Recorded Webcast
Credits
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 Participation
Cost $0.00

Pages